Creating new methods to make specific bioactive molecules
Development of Strategies for the Enantioselective Synthesis of Heterocycles and Acyclic Amines
['FUNDING_R01'] · UNIVERSITY OF FLORIDA · NIH-11077840
This study is looking at new ways to make special molecules that can help create important medicines, using a unique tool that improves chemical reactions, especially for complex compounds.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF FLORIDA (nih funded) |
| Locations | 1 site (GAINESVILLE, UNITED STATES) |
| Trial ID | NIH-11077840 on ClinicalTrials.gov |
What this research studies
This research focuses on developing innovative synthetic methods to create bioactive molecules with specific chiral properties. By utilizing a new class of chiral biaryl ligands, the project aims to enhance the efficiency of copper-catalyzed reactions that form carbon-carbon bonds. The researchers will explore the unique behaviors of these ligands to enable new chemical reactions, particularly those involving complex nitrogen-containing heterocycles. This work could lead to the rapid synthesis of important natural products and building blocks used in pharmaceuticals.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that could be treated by new bioactive molecules developed through these synthetic methods.
Not a fit: Patients who are not affected by conditions treatable with the newly synthesized bioactive molecules may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and targeted treatments in medicine by providing new ways to synthesize important bioactive compounds.
How similar studies have performed: Other research has shown promise in developing new synthetic methods for bioactive molecules, but this specific approach using atropisomeric chiral biaryl ligands is relatively novel.
Where this research is happening
GAINESVILLE, UNITED STATES
- UNIVERSITY OF FLORIDA — GAINESVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: APONICK, AARON — UNIVERSITY OF FLORIDA
- Study coordinator: APONICK, AARON
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.